CAS, Molecule.one team up to transform chemical synthesis planning for drug discovery
As part of the efforts to improve their solutions, CAS will integrate Molecule.one's deep learning models for better…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Aug 23
As part of the efforts to improve their solutions, CAS will integrate Molecule.one's deep learning models for better…
14 Aug 23
As part of the collaboration, Logomix will initially contribute genome editing capabilities to assist HebeCell in creating the…
14 Aug 23
ZM008 is a human IgG1 monoclonal antibody against LLT1 (CLEC2D), which disrupts the interaction of LLT1-CD161 between human…
11 Aug 23
Inversago’s lead asset, INV-202, specifically blocks the receptor protein CB1, which plays key role in metabolism and appetite…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
11 Aug 23
The investment will help Astellas to establish a significant presence in life science innovation hotspots in the world…
11 Aug 23
Under the agreement, Antengene will retain its responsibilities for R&D, regulatory approvals and affairs, product supply, and distribution…
11 Aug 23
Under the collaboration, Boostimmune will have access to WuXi Biologics' integrated discovery services and extensive expertise in antibody…
10 Aug 23
As part of the expansion of the Milan site, AGC Biologics has added five suspension single-use bioreactors, including…
10 Aug 23
Under the agreement, T-MAXIMUM Biotech will get several CRISPR reagents from GenScript to aid in the development of…
10 Aug 23
The proposed acquisition will enhance the ongoing partnership between Decibel and Regeneron and the partnership aims to expedite…